Oxycodone

🧮 Dose calculator

Severe pain requiring an opioid · Regimen source: FDA Oxycodone IR · 2.3

• • Lowest effective dose for the shortest time. “Every 4–6 h as needed”; the calculator shows 6-hourly. Conversion from other opioids per label. FDA Oxycodone IR · 2.1FDA Oxycodone IR · 2.3

Enter age (weight is optional for this regimen).

👥 Special populations

• 🤰 PregnancyDangerous / avoid

  Label: can cause fetal harm. Dangerous in pregnancy. FDA Oxycodone IR · Boxed Warning

  “Neonatal Opioid Withdrawal Syndrome (NOWS) Advise pregnant women using opioids for an extended period of time of the risk of Neonatal Opioid Withdrawal Syndrome , which may be life-threatening if not recognized and treated.”

• 🤱 BreastfeedingUse with caution

  Label: use with caution while breastfeeding; see the label text. FDA Oxycodone IR · 8.2

  “Risk Summary Available data from lactation studies indicate that oxycodone is present in breastmilk and that doses of less than 60 mg/day of the immediate-release formulation are unlikely to result in clinically relevant exposures in breastfed infants.”

• 👶 ChildrenSafety not established

  Label: not evaluated in children. Accidental ingestion of even one dose by a child can be fatal. FDA Oxycodone IR · 8.4

  “The safety and efficacy of oxycodone hydrochloride tablets in pediatric patients have not been evaluated.”

• 👴 Older adultsUse with caution

  Label: use with caution in older adults, usually starting at the low end of the dose range. FDA Oxycodone IR · 8.5

  “In general, use caution when selecting a dosage for an elderly patient, usually starting at the low end of the dosing range, reflecting the greater frequency of decreased hepatic, renal, or cardiac function and of concomitant disease or other drug therapy.”

• ⚥ Females & males of reproductive potentialUse with caution

  Label has advice on pregnancy testing, contraception or fertility for females and males. FDA Oxycodone IR · 8.3

  “Infertility Use of opioids for an extended period of time may cause reduced fertility in females and males of reproductive potential.”